Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA - Tsuboi, M; Weder, W; Escriu, C (Future Oncol, 2021)
et al.